small molecule

PURIXAN

MERCAPTOPURINE

Loss of exclusivityloss of exclusivity
CompanyNOVA LABORATORIES LTD

Drug detail

Brand namePURIXAN
Active ingredientMERCAPTOPURINE
Strength20MG/ML
Dosage formSUSPENSION
RouteORAL
ModalitySmall molecule
FDA approvalApril 2014
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

PURIXAN patent cliff — loss of exclusivity — | CliffBio